Journal article
Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction
Abstract
A subgroup meta-analysis from the Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) and the Thrombolysis in Myocardial Infarction (TIMI) 11B studies has shown that enoxaparin is superior to unfractionated heparin in reducing the composite end points of death, myocardial infarction, and emergency revascularization in patients with Q-wave myocardial infarction. The beneficial treatment effect was significant …
Authors
Cohen M; Antman EM; Gurfinkel E; Turpie AGG; Furst J; Bigonzi F; Radley D
Journal
The American Journal of Cardiology, Vol. 86, No. 5, pp. 553–556
Publisher
Elsevier
Publication Date
September 2000
DOI
10.1016/s0002-9149(00)01014-6
ISSN
0002-9149